Abiopharma

🔍 Beranek Cheryl (Director)

Company: Clearfield, Inc. (CLFD)

Report Date: 2026-05-08

Detailed Transactions and Holdings:

• Sold 5,000 shares of Common Stock at $40.27 per share (Direct)
  Date: 2026-05-08 | Code: S | equity_swap_involved: 0 | shares_owned_after: 507,041.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 2,500 shares of Common Stock at $45.02 per share (Direct)
  Date: 2026-05-11 | Code: S | equity_swap_involved: 0 | shares_owned_after: 504,541.00 | transaction_form_type: 4 | Footnotes: F1, F3

Footnotes:

• F1: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2025.
• F2: The price in column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.63. The reporting person undertakes to provide Clearfield, Inc., any security holder of Clearfield, Inc., or the staff of the Securities and Exchange Commission, upon request, with full information regarding the number of shares sold at each separate price set forth in the footnote.
• F3: The price in column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $45.15. The reporting person undertakes to provide Clearfield, Inc., any security holder of Clearfield, Inc., or the staff of the Securities and Exchange Commission, upon request, with full information regarding the number of shares sold at each separate price set forth in the footnote.